Children with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment or that has relapsed may ...

Children with a rare form of cancer called neuroblastoma which hasn't responded to initial treatment or that has relapsed may ...

Ovarian01 Phase 3 Trial of ENHERTU® Initiated as First-Line Maintenance Therapy in Patients with HER2 Expressing Advanced ...

Gut dysbiosis caused by gastric acid suppression has been shown to affect the efficacy of immune checkpoint inhibitor treatment in some cancers, but not in HCC.

Philadelphia, PA, USA, December 9, 2025, First Patient Enrolled in GOG-3133/ FRAmework-01 Phase 3 Study Evaluating Sofetabart ...

The share-swap ratio has been fixed at 70.28 Biocon shares for every 100 Biocon Biologics shares, at a share price of Rs ...

Eric H. Yang, MD, warns that lifetime cardiovascular risk for patients with breast cancer may exceed the general population as life expectancies grow, emphasizing the need for early intervention.

Daiichi Sankyo has announced the dosing of first patient in the DESTINY-Ovarian01 Phase III trial’s randomisation phase, ...

Positive opinion from European Medicines Agency supports approval for golimumab biosimilar Gotenfia® developed by Bio-Thera ...

The first patient has been dosed in the randomization phase of the DESTINY-Ovarian01 phase 3 trial evaluating Enhertu in combination with ...

FiscalNote Holdings, Inc. ("FiscalNote"), a leading provider of AI-driven policy and regulatory intelligence solutions, today announced that members of the senior management team will be participating ...